Skip to main content

Table 2 Demographic, clinical and laboratory features, treatment and outcome of SLE patients with HIV

From: Human immunodeficiency virus in a cohort of systemic lupus erythematosus patients

Case

Gender

First DX

Clinical features

Autoantibodies

SLE treatment

ART

CD4 at DXa

Last CD4

Outcome

1

F

SLE

Discoid lupus, photosensitivity, oral ulcers and arthritis

ANA and anti-Ro

CS

Yes

434

337

Good health condition, but loss of follow-up in the Rheumatology Clinic

2

F

SLE

Raynaud, arthritis and vasculitis

ANA, anti-dsDNA, anti-Ro and anti-La

CS

Yes

572

205

Disseminated TB at 2015, follow-up in the Infectious Diseases Clinic

3

F

SLE

Arthritis, leucopenia, lymphopenia, alopecia, Raynaud and photosensitivity

ANA

HCQ

Yes

424

1056

SLE in remission, HIV controlled

4

F

SLE

Discoid lupus, photosensitivity, nephritis, leucopenia and lymphopenia

ANA

HCQ

Yes

149

524

HCV coinfection

SLE in remission and HIV controlled

5

F

SLE

Photosensitivity, oral ulcers, arthritis and nephritis

ANA, anti-Ro and anti-La

CS, AZA ➔ MMF and tacrolimus

Yes

273

991

Pulmonary TB in 2008, kidney transplantation in 2011

6

F

SLE

Photosensitivity, serositis and arthritis

ANA

None

Yes

172

391

HCV coinfection,

SLE in remission and HIV controlled

7

F

SLE

Alopecia, arthritis, nephritis, hemolytic anemia and hypergammaglobulinemia

ANA, anti-dsDNA and anti-Ro

HCQ, CYC

➔ AZA

Yes

321

165

Good initial response, poor adherence to treatment with posterior reactivation of nephritis and CD4 count drop

8

F

HIV

Hemolytic anemia, serositis, oral ulcers and arthritis

ANA, anti-Sm and anti-RNP

HCQ, MTX

Yes

NA

477

CMV Retinitis in 2006,

SLE in remission and HIV controlled

9

F

HIV

Hemolytic anemia and nephritis

ANA and anti-dsDNA

CS, HCQ

CYC ➔ AZA

Yes

235

252

Complete response to CYC, posterior poor adherence and loss of follow-up due to drug addiction

10

F

SLE

Hemolytic anemia, serositis, leucopenia, lymphopenia, oral ulcers, arthritis and nephritis

ANA and anti-dsDNA

HCQ

Yes

203

323

SLE in remission and HIV controlled

11

F

Both

Alopecia, hemolytic anemia, nephritis, thrombocytopenia, leucopenia and lymphopenia

ANA

CS, HCQ

➔AZA

Yes

111

NA

Both diagnosed in hospital stay, progressing to death from sepsis

  1. Abbreviations: ACL IgG anti-cardiolipin IgG, ACL IgM anti-cardiolipin IgM, ANA anti-nuclear antibody, ART active antiretroviral therapy, AZA azathioprine, CMV cytomegalovirus, CS corticosteroids, CYC cyclophosphamide, dsDNA anti-double-stranded DNA, DX diagnosis, F female, HCQ hydroxychloroquine, HIV human immunodeficiency virus, M male, MMF mycophenolate mofetil, MTX methotrexate, NA not available, SLE systemic lupus erythematosus, TB tuberculosis
  2. aCD4 cell count at diagnosis of HIV-infection: cells/mm3